A comprehensive evaluation of interpretable artificial intelligence for epileptic seizure diagnosis using an electroencephalogram: A systematic review

利用脑电图对可解释人工智能进行癫痫发作诊断的综合评估:系统评价

阅读:2

Abstract

BACKGROUND: Epilepsy is a sensitive social and health issue that causes sudden death in epilepsy. Awake and sleep electroencephalogram (EEG) first test confirms 80% of patients with confirmed epilepsy. Explainable artificial intelligence (XAI) for epileptic seizures (ESs) emerged to overcome drawbacks of artificial intelligence (AI) models like lack of right to explain, fairness, and trustworthiness, and an overwhelming paper was published. However, there is a lack of reporting interpretable and performance tradeoffs, stating the most interpretable AI applied, describing the most useful waveforms learned in XAI models, documenting areas of interest, and identifying the relationship between frequency bands and epilepsy. Therefore, this systematic review aims to comprehensively evaluate the performance and the interpretability of interpretable AI methods used for ES monitoring using an EEG. METHODS: This study followed PRISMA guidelines for systematic review. Advanced search queries were hardheaded into five reputable databases. Rayyan online platform for a systematic review was used. The disagreement was resolved through discussions. RESULTS: Twenty-three papers are included. A total of 14 datasets are used. A total of 16,200 populations are participated in all the included studies. CHB-MIT Dataset is frequently used (12 times). Minimizing the number of waveforms learned will increase the accuracy and reduce the memory used. Interpretability to accuracy trade-offs are observed in the studies included. DISCUSSION: The result of this systematic review implies that further studies are needed on interpretable to accuracy tradeoffs, multi-modal care recommendations, and onset early warning to minimize sudden unexpected death in epilepsy and damage. Optimizing waveforms for ESs needs more investigation. Subjective matrices must be investigated very well before being used by XAI. This study has no ethical considerations associated with it. It has been registered with PROSPERO: registration number: CRD42023479926.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。